cough
singl
common
reason
given
patient
seek
treatment
primari
australia
acut
medic
consult
millionyear
cough
among
present
children
chronic
cough
durat
previou
month
mani
like
seen
doctor
symptom
five
chronic
cough
childhood
also
associ
consider
decreas
qualiti
life
qol
normal
cough
resolv
follow
appropri
mani
possibl
etiolog
recruit
primarili
pediatr
referr
center
found
protract
bacteri
bronchiti
pbb
common
caus
chronic
cough
childhood
exceed
underli
diagnos
includ
asthma
articl
summar
current
knowledg
pbb
children
present
preliminari
data
underli
diseas
mechan
identifi
research
prioriti
help
close
inform
gap
common
poorli
understood
condit
initi
pbb
criteria
deriv
clinic
observ
initi
pbb
criteria
valid
exampl
chronic
wet
cough
week
studi
parent
recognit
wet
cough
show
excel
agreement
pediatr
pulmonologist
kappa
confid
interv
ci
bronchoscop
find
endobronchi
secret
area
receiv
oper
curv
ci
also
studi
demonstr
bal
cultur
children
chronic
wet
cough
respiratori
bacteri
densiti
cfuml
indic
lower
airway
infect
increas
amount
secret
detect
bronchoscopi
associ
increas
likelihood
infect
airway
origin
ii
requir
bal
specimen
posit
respiratori
bacteri
cultur
threshold
often
use
diagnos
lower
airway
common
pathogen
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
report
initi
reaffirm
sever
final
cochran
review
two
random
control
trial
rct
found
antibiot
improv
odd
cure
chronic
wet
cough
children
odd
ratio
ci
although
rct
limit
small
number
total
n
nevertheless
provid
experiment
data
support
clinic
observ
result
confirm
recent
nonetheless
criteria
describ
limit
recogn
wet
cough
depend
upon
clinic
set
child
age
accuraci
parentcaregiv
histori
healthcar
personnel
train
experi
influenc
accur
identif
exampl
unlik
australian
indigen
caregiv
report
current
cough
often
also
easier
recogn
spontan
wet
cough
young
child
agreement
clinician
parent
cough
qualiti
drywet
better
children
age
year
ci
older
children
ci
experi
older
children
may
underli
product
cough
despit
sound
dri
ask
cough
clinic
cough
request
may
partial
relat
secret
volum
rel
airway
size
describ
anim
studi
amount
secret
alter
sound
lower
airway
infect
often
defin
bacteri
growth
cfuml
robust
remain
thu
differ
studi
employ
bal
use
slightli
differ
definit
pbb
tabl
although
respons
week
antibiot
one
criteria
use
diagnos
pbb
observ
children
requir
longer
treatment
week
number
need
treat
benefit
week
found
cochran
ci
possibl
use
longer
cours
may
reduc
see
variat
definit
similar
pediatr
asthma
vari
definit
depend
upon
age
clinic
andor
research
set
avail
test
airway
cellular
lung
function
airway
given
limit
definit
pbb
may
refin
particularli
simpl
biomark
identifi
predict
respons
antibiot
advanc
field
clariti
propos
follow
definit
origin
modifi
criteria
bal
compon
replac
absenc
caus
wetproduct
cough
cough
resolv
week
antibioticsrecurr
pbb
recurr
episod
per
year
pbb
first
describ
pbb
exist
distinct
diagnost
entiti
howev
becom
recogn
increasingli
incorpor
pediatr
chronic
cough
guidelin
tabl
european
pediatr
respiratori
train
astut
clinician
allud
condit
previous
consolid
observ
clinic
entiti
support
data
variou
definit
use
describ
childhood
chronic
bronchiti
rang
product
cough
monthsyear
recurr
episod
cough
last
week
withwithout
period
singl
center
review
children
undergo
bronchoscopi
diagnos
chronic
bronchiti
found
evid
bronchial
wall
inflamm
purul
endobronchi
secret
improv
cours
seri
studi
childhood
bronchiectasi
rais
possibl
revers
aggress
antibiot
treatment
anoth
studi
suggest
link
chronic
bronchiti
later
report
describ
chronic
bacteri
bronchiti
children
recent
other
suggest
children
call
difficult
asthma
persist
might
pbb
parent
children
pbb
often
describ
wheez
ill
inde
retrospect
french
studi
report
one
eight
children
undergo
bronchoscopi
sever
chronic
asthma
lower
airway
infect
defin
cfuml
cfuml
activ
neutrophil
true
preval
pbb
case
present
commun
clinic
unknown
studi
specialist
clinic
found
pbb
among
top
three
diagnos
children
chronic
cough
tabl
use
standard
manag
priori
definit
valid
cough
outcom
measur
australian
multicent
found
children
newli
refer
chronic
cough
pbb
predomin
younger
unit
kingdom
uk
retrospect
studi
report
pbb
common
diagnosi
made
clinic
children
refer
difficult
asthma
chronic
cough
disord
increas
limit
data
qol
children
pbb
parent
studi
gener
chronic
qol
score
children
pbb
similar
differ
diagnost
group
asthma
bronchiectasi
whose
chronic
cough
resolv
without
treatment
present
pediatr
importantli
qol
score
normal
cough
typic
diagnosi
children
pbb
receiv
multipl
medic
consult
sever
health
sheffield
report
time
referr
children
pbb
take
asthma
treatment
australian
studi
found
children
diagnosi
receiv
asthma
medic
seen
doctor
previous
persist
howev
find
also
similar
children
chronic
cough
rel
clinic
studi
children
pbb
tabl
definit
chronic
wet
cough
although
children
pbb
typic
young
mean
median
age
year
tabl
pbb
also
occur
older
year
first
cohort
children
pbb
lack
system
symptom
includ
evid
sinus
ear
confirm
subsequ
prospect
cohort
compar
diseas
control
undergo
bronchoscopi
indic
eg
stridor
apnea
children
pbb
like
attend
childcar
ci
tobacco
smoke
exposur
similar
control
strong
associ
childcar
attend
rais
possibl
respiratori
virus
role
initi
pbb
least
children
children
pbb
typic
appear
well
normal
growth
develop
lack
sign
underli
chronic
suppur
lung
diseas
csld
digit
club
chest
wall
deform
adventiti
auscultatori
chest
although
occasion
rattli
chest
crackl
heard
chest
radiograph
normal
show
perform
respiratori
system
reactanc
resist
measur
forc
oscillatori
techniqu
unpublish
also
normal
preval
atop
featur
eczema
system
airway
eosinophilia
elev
ige
posit
radioallergosorb
test
similar
children
without
mani
parent
report
previou
ever
wheez
wheez
doctor
unusu
iowa
citi
retrospect
cohort
children
children
noisi
breath
five
also
wheez
parent
report
wheez
sheffield
cohort
children
refer
difficult
asthma
report
short
breath
attribut
cough
bout
children
pbb
base
upon
definit
sinc
requir
six
cours
antibiot
recurr
chronic
wet
cough
bronchiectasi
children
differenti
acut
bronchiti
pbb
base
fact
acut
bronchiti
cough
usual
resolv
within
nevertheless
difficulti
aris
recurr
acut
bronchiti
episod
overlap
especi
respiratori
viru
season
furthermor
pbb
ill
includ
asthma
recurr
episod
need
differenti
bronchiectasi
chronic
wet
cough
repeat
respiratori
exacerb
may
respond
oral
antibiot
physic
sign
csld
may
develop
irrevers
bronchial
dilat
wall
thicken
seen
plain
radiograph
comput
tomographi
ct
scan
pbb
child
cough
resolv
prolong
week
cours
appropri
typic
five
seven
day
cours
antibiot
prescrib
cough
either
relaps
resolv
complet
howev
children
requir
week
treatment
mani
children
whose
cough
cure
week
antibiot
underli
need
longer
cours
antibiot
cough
disappear
specul
children
also
sever
end
diseas
spectrum
like
requir
longer
antibiot
cours
henc
larger
ci
compar
cochran
review
ci
contrast
british
thorac
societi
bt
cough
suggest
children
pbb
receiv
week
antibiot
recommend
howev
base
upon
expert
opinion
time
support
studi
exist
studi
need
help
identifi
whether
pbb
requir
longer
cours
antibiot
differ
eg
outcom
respond
shorter
cours
children
pbb
may
need
longer
antibiot
treatment
still
advoc
shorter
cours
initi
reflect
principl
good
antimicrobi
stewardship
also
reduc
advers
event
furthermor
recent
studi
show
children
chronic
wet
cough
fail
resolv
week
appropri
oral
antibiot
increas
likelihood
bronchiectasi
chest
ct
retrospect
studi
chest
ct
scan
perform
month
period
assess
chronic
wet
cough
among
children
persist
cough
despit
least
week
antibiot
bronchiectasi
children
whose
cough
resolv
antibiot
six
receiv
diagnosi
adjust
ci
chest
airway
clearanc
standard
therapi
bronchiectasi
bt
also
suggest
physiotherapi
children
pbb
may
benefici
evid
support
recommend
limit
furthermor
time
requir
perform
airway
clearanc
techniqu
underestim
ideal
lower
airway
specimen
microbiolog
test
obtain
treatment
inde
bt
recommend
make
diagnosi
pbb
sputum
cultur
first
underli
condit
exclud
howev
children
chronic
wet
cough
young
tabl
unabl
expector
even
follow
sputum
induct
thu
obtain
reliabl
lower
respiratori
secret
requir
bronchoscopi
impract
clinic
set
nevertheless
bronchoscopi
perform
purul
secret
evid
bronchiti
fig
usual
present
consequ
pragmat
perspect
children
isol
chronic
wet
cough
normal
near
normal
chest
radiograph
without
symptom
sign
anoth
diagnosi
eg
aspir
lung
diseas
bronchiectasi
cystic
fibrosi
cf
inhal
foreign
bodi
tuberculosi
etc
pbb
suspect
recommend
receiv
week
appropri
oral
antibiot
wide
use
first
line
empir
antibiot
commonli
associ
pathogen
h
influenza
especi
catarrhali
although
depend
upon
local
pathogen
suscept
pattern
altern
oral
cephalosporin
macrolid
may
use
immedi
hypersensit
penicillin
exist
antibiot
gener
well
toler
caregiv
counsel
possibl
advers
event
eg
gastrointestin
complaint
rash
hypersensit
child
expector
sputum
specimen
obtain
minor
children
cough
respond
treatment
antibiot
extend
maximum
week
howev
time
wet
cough
improv
substanti
child
investig
caus
chronic
wet
pbb
also
condit
eg
asthma
condit
diagnos
manag
concurr
children
risk
chronic
lung
diseas
clinician
also
counsel
prevent
care
includ
avoid
tobacco
smoke
inhal
environment
toxic
time
vaccin
ensur
good
nutrit
emphas
import
physic
activ
pbb
often
recur
point
particularli
young
recurr
respiratori
infect
common
age
definit
recurr
number
episod
per
year
remain
uncertain
histor
either
least
three
three
lower
respiratori
infect
per
year
adopt
latter
definit
prospect
studi
undertaken
children
pbb
follow
median
month
iqr
median
age
bronchoscopi
month
iqr
compar
healthi
control
median
age
month
iqr
children
pbb
baselin
significantli
like
wet
cough
visit
famili
doctor
preced
month
month
children
pbb
like
cough
compar
control
vs
respect
cohort
p
wheez
preced
month
vs
p
end
studi
pbb
complet
experienc
recurr
episod
per
year
bronchiectasi
diagnos
chest
ct
major
independ
risk
factor
bronchiectasi
h
influenza
lower
airway
infect
sibl
h
influenza
infect
confer
time
higher
risk
bronchiectasi
h
influenza
neg
state
hazard
ratio
ci
retrospect
describ
children
whose
wet
cough
resolv
antibiot
pbb
median
period
month
iqr
eight
remain
cough
free
three
three
recurr
episod
persist
wet
cough
nine
prescrib
antibiot
anoth
retrospect
report
children
recurr
symptom
timefram
provid
studi
suggest
physician
warn
parent
futur
recurr
physician
need
awar
children
may
progress
bronchiectasi
nevertheless
actual
rate
risk
factor
pbb
recurr
like
depend
sampl
frame
definit
factor
sever
enough
proceed
bronchoscopi
like
differ
enrol
commun
addit
longer
term
studi
warrant
recurr
pbb
associ
intens
possibl
persist
activ
interleukin
il
signal
pathway
first
descript
bal
cultur
grew
common
respiratori
bacteri
pathogen
pneumonia
h
influenza
catarrhali
subsequ
sever
group
confirm
bal
one
retrospect
studi
also
identifi
staphylococcu
aureu
children
quantit
bacteriolog
perform
make
interpret
difficult
latter
also
evalu
bal
sampl
one
versu
six
lobe
report
sampl
one
lobe
children
would
miss
potenti
bacteri
pathogen
patient
gener
accept
one
lobe
undergo
bal
addit
prospect
studi
employ
quantit
bacteriolog
concomit
inflamm
marker
assay
need
data
relat
current
recent
antibiot
use
vaccin
statu
also
record
like
antibiot
vaccin
type
host
immun
respons
influenc
lower
airway
bacteriolog
children
suspect
h
influenza
rang
common
bacteria
report
publish
studi
describ
lower
airway
bacteriolog
children
h
influenza
h
influenza
nthi
strain
repres
divers
find
consist
increas
import
nthi
chronic
pulmonari
disord
children
pneumonia
second
common
organ
detect
bal
cultur
catarrhali
rang
found
commonli
howev
bal
studi
difficult
compar
sampl
came
differ
site
number
lobe
accept
posit
cultur
other
use
quantit
bacteriolog
diagnos
pneumonia
serotyp
report
one
recent
studi
involv
immun
children
uk
greec
undergo
bal
suspect
although
vaccin
serotyp
isol
bal
cultur
vaccin
serotyp
found
significantli
less
often
children
receiv
pneumococc
conjug
final
cultur
two
bacteri
pathogen
report
frequent
sever
influenc
clinic
present
outcom
comment
upon
surprisingli
one
studi
examin
systemat
presenc
respiratori
virus
children
studi
report
higher
rate
viru
detect
pcr
bal
fluid
pbb
case
chronic
respiratori
diseas
control
vs
ci
common
viru
identifi
adenoviru
adv
upon
genotyp
belong
predominantli
adv
speci
children
pbb
adv
posit
group
howev
significantli
younger
pbb
adv
neg
group
median
iqr
vs
iqr
month
p
posit
associ
found
adv
detect
bacteri
infect
disappear
adjust
extend
panel
virus
undertaken
subset
children
found
rhinoviru
human
bocaviru
human
coronaviru
preval
virus
similar
control
studi
also
report
similar
preval
virus
asymptomat
microbiota
lung
children
pbb
examin
singl
use
bacteri
rrna
gene
pyrosequenc
phylogenet
analysi
ecolog
statist
tool
core
microbiota
sputum
bal
specimen
children
pbb
n
bronchiectasi
cf
control
adult
bronchiectasi
cf
chronic
pulmonari
disord
analysi
varianc
show
index
measur
speci
divers
lower
airway
microbiota
children
pbb
bronchiectasi
similar
statist
higher
ie
richer
cf
fig
howev
three
pediatr
cohort
share
remark
similar
core
microbiota
h
influenza
make
greatest
contribut
observ
similar
lung
microbiota
children
significantli
differ
observ
adult
cf
bronchiectasi
fig
find
suggest
chronic
airway
infect
begin
similarli
defect
airway
clearanc
otherwis
normal
airway
microbiota
time
antibiot
treatment
perhap
effect
underli
diseas
microbiota
diseas
group
progress
diverg
one
anoth
biofilm
may
anoth
specul
reason
chronic
need
longer
antibiot
cours
pbb
treatment
group
first
document
biofilm
bal
fluid
children
preliminari
data
show
biofilm
also
present
bal
fluid
children
pbb
none
children
pseudomona
aeruginosa
subsequ
describ
system
immun
children
pbb
confirm
absenc
overt
immunodefici
serum
level
iga
igm
igg
ige
normal
respons
protein
tetanu
conjug
h
influenza
type
b
vaccin
humor
immun
therefor
seem
intact
abnorm
lymphocyt
subset
innat
immun
among
children
pbb
also
appear
activ
rather
one
innat
immun
assess
examin
receptor
tlr
signal
pattern
recognit
receptor
play
key
role
respond
invad
bacteria
especi
bacteria
compar
control
bal
sampl
children
pbb
significantli
elev
mrna
rel
tabl
whether
bal
children
pbb
reduc
tlr
express
level
prior
earli
infect
unknown
opportunist
studi
children
undergo
gastroscopi
gastrointestin
symptom
found
mrna
rel
express
significantli
lower
children
chronic
cough
bal
evid
bacteri
infect
cfuml
without
second
larger
studi
evalu
pulmonari
level
three
innat
immun
compon
human
lectin
mbl
surfact
cytokin
product
bal
cell
children
current
pbb
previous
treat
pbb
diseas
control
undergo
bronchoscopi
airway
assess
median
mbl
level
significantli
higher
current
previou
pbb
group
control
tabl
level
cytokin
product
stimul
bal
cell
similar
among
preliminari
studi
system
immun
respons
cytokin
product
nthi
children
pbb
similar
healthi
control
howev
depend
proinflammatori
pathway
activ
pbb
children
defici
efferocytosi
impair
clearanc
apoptot
cell
alveolar
macrophag
anoth
possibl
mechan
pbb
pathobiolog
postul
apoptot
cell
may
undergo
secondari
necrosi
effect
contribut
perpetu
chronic
inflamm
infect
tissu
support
hypothesi
come
small
studi
show
significantli
decreas
abil
alveolar
macrophag
phagocytos
apoptot
bronchial
cell
nthi
children
bronchiectasi
n
pbb
n
compar
control
n
type
impair
phagocytosi
valu
children
pbb
intermedi
tabl
neutrophil
influx
import
featur
innat
immun
respons
other
describ
intens
airway
neutrophilia
median
children
whether
patholog
disproportion
respons
infect
unknown
also
mark
mediat
respons
matrix
metalloproteinas
mmp
activ
correl
bal
neutrophil
median
bal
level
children
pbb
higher
control
whose
cough
resolv
without
specif
level
also
significantli
correl
r
p
shown
experiment
valid
cohort
children
pbb
significantli
higher
bal
fluid
level
pathway
member
gene
protein
express
diseas
level
correl
durat
sever
elev
express
pbb
case
recurr
pbb
next
month
baselin
bronchoscopi
gene
express
signal
molecul
receptor
associ
kinas
irak
significantli
higher
without
recurr
pbb
suggest
pathway
involv
innat
immun
factor
relat
wet
cough
airway
neutrophilia
specif
studi
children
pbb
includ
pattern
recognit
receptor
advanc
glycat
rage
play
import
complex
role
mani
inflammatori
respons
within
solubl
rage
srage
level
within
circul
bal
fluid
associ
age
airway
inflammatori
cell
profil
lower
srage
airway
neutrophilia
highlight
potenti
import
role
srage
pediatr
lung
older
studi
show
associ
among
airway
lesion
chronic
chronic
clinician
believ
caus
chronic
cough
like
infect
predispos
individu
prolong
ineffici
airway
clearanc
sinc
cough
resolv
underli
infect
treat
suggest
malacia
limit
caus
nevertheless
impair
airway
increas
likelihood
persist
lower
airway
infect
inflamm
also
found
commonli
children
associ
may
primari
airway
malacia
predispos
pbb
reduc
effici
airway
clearanc
secondari
malacia
develop
intens
airway
one
retrospect
studi
report
present
children
howev
prospect
studi
involv
children
pbb
found
airway
abnorm
common
children
pbb
undergo
bronchoscopi
respiratori
indic
tertiari
pediatr
hospit
vs
respect
nevertheless
proport
higher
estim
gener
popul
littl
doubt
children
higher
frequenc
respiratori
infect
propos
paradigm
fig
pbb
csld
bronchiectasi
share
common
underli
pathobiolog
mechan
progress
variabl
along
increas
spectrum
current
evid
suggest
paradigm
still
remain
clinic
use
ensur
children
bronchiectasi
miss
pbb
overlap
csld
turn
overlap
children
establish
bronchiectasi
would
csld
stage
earlier
diseas
process
csld
would
pbb
previous
potenti
injuri
persist
infect
inflamm
probabl
import
grow
develop
lung
young
children
matur
lung
support
anim
human
studi
earli
lung
insult
like
advers
children
pbb
typic
plausibl
recurr
pbb
episod
risk
factor
develop
csld
bronchiectasi
similar
three
condit
includ
chronic
wet
cough
breath
ruttl
well
impair
region
clearanc
endobronchi
bacteri
infect
neutrophil
airway
inflamm
core
cultur
classic
respiratori
bacteri
pathogen
also
similar
pediatr
csld
key
differ
three
entiti
lie
sever
symptom
sign
respons
week
oral
antibiot
chest
ct
scan
find
consequ
manag
csld
differenti
bronchiectasi
lack
radiograph
sign
bronchiectasi
chest
ct
addit
consolid
preliminari
data
present
import
research
question
remain
answer
surprisingli
common
poorli
recogn
pulmonari
disord
epidemiolog
pathobiolog
manag
research
goal
list
tabl
